The Association for Molecular Pathology announced the publication of best practice recommendations for clinical laboratories developing and performing homologous recombination deficiency (HRD) testing ...

NEW YORK – The Association for Molecular Pathology on Tuesday published best practice recommendations for the design and validation of clinical tests for homologous recombination deficiency. The ...

The Association for Molecular Pathology, the premier global molecular diagnostic professional society, today announced the publication of best practice recommendations for clinical laboratories ...

Expert witnesses in toxicology and forensic pathology testified in the second day of the murder trial for Marcy Oglesby.

A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says ...

Agilent’s second quarter results reflected broad-based growth across most end markets and geographies, with particular ...

Blood levels of a protein called neurofilament light chain rise significantly in MS patients up to a year before they have a ...

A novel molecular imaging agent targeting glypican-3 (GPC3) has demonstrated high sensitivity and specificity in detecting ...

More than 7 million people have Alzheimer’s disease here in the United States. Now, a new blood test may be able to help with ...

is the first FDA cleared blood-based IVD test in the U.S. to aid to identify patients with amyloid pathology associated with Alzheimer’s Disease (AD). Alzheimer’s disease currently affects an ...

Dr. Bernick said the new blood test, which was just approved by the FDA, is for adults over the age of 55 who are showing signs of Alzheimer’s disease. Alzheimer’s is the most common cause for ...

Adding genetic testing to clinical familial hypercholesterolemia screening improves risk assessment, prognosis and helps to guide targeted therapy.